40 results
Page 2 of 2
8-K
EX-10.1
3h3wwfv0u6he30m8c
23 Mar 20
Departure of Directors or Certain Officers
7:31am
10-Q
t6xzgnwpzybu
9 May 19
Quarterly report
7:13am
10-K
c4g1fmb8d7ot57jp
28 Feb 19
Annual report
1:08pm
10-K
EX-10.12
mklc3a mwv9zafk7w
28 Feb 19
Annual report
1:08pm
424B5
1y5549v dqqzamwvo
25 Jan 19
Prospectus supplement for primary offering
8:01am
424B5
ijst 0fevrodk
22 Jan 19
Prospectus supplement for primary offering
5:12pm
8-K
EX-99.2
0bksb4
22 Jan 19
UroGen Pharma Announces Proposed Public Offering of Ordinary Shares
5:08pm
6-K
EX-99.1
ishfqb4
31 Oct 18
UGN-101 Joins Select Group of Urologic Oncology Product Candidates to Receive BTD
3:36pm
6-K
EX-99.3
apaxd irxn9l0v2
12 Jul 18
UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors
8:07pm
6-K
EX-99.2
u95b4y73vq4d60l45woc
12 Jul 18
UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors
8:07pm
20-F
2q96oa1f
15 Mar 18
Annual report (foreign)
12:00am
424B4
dy7sutx0e8kv8
22 Jan 18
Prospectus supplement with pricing info
12:00am
DRSLTR
2fd95uwvddp7a6uf
28 Dec 16
Correspondence regarding draft registration statement
12:00am